Cite
HARVARD Citation
Wang, T. et al. (2022). Chimeric antigen receptor T‐cell therapy combined with autologous stem cell transplantation improved progression‐free survival of relapsed or refractory diffuse large B‐cell lymphoma patients: A single‐center, retrospective, cohort study. Hematological oncology. 40 (4), pp. 637-644. [Online].